Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Oct 8:11:586910.
doi: 10.3389/fgene.2020.586910. eCollection 2020.

Cardiovascular Problems in the Fragile X Premutation

Nattaporn Tassanakijpanich  1   2 , Jonathan Cohen  3 , Rashelle Cohen  3 , Uma N Srivatsa  4 , Randi J Hagerman  1   5
Affiliations

Cardiovascular Problems in the Fragile X Premutation

Nattaporn Tassanakijpanich et al. Front Genet. .

Abstract

There is a dearth of information about cardiovascular problems in fragile X premutation carriers who have 55-200 CGG repeats in fragile X mental retardation 1 (FMR1) gene. The FMR1 expansion in the premutation range leads to toxic RNA gain-of-function resulting in cellular dysregulation. The mechanism of RNA toxicity underlies all of the premutation disorders including fragile X-associated tremor/ataxia syndrome, fragile X-associated primary ovarian insufficiency, and fragile X-associated neuropsychiatric disorder. Cardiovascular problems particularly autonomic dysfunction, hypertension, and cardiac arrhythmias are not uncommon in premutation carriers. Some arterial problems and valvular heart diseases have also been reported. This article reviews cardiovascular problems in premutation carriers and discusses possible contributing mechanisms including RNA toxicity and mild fragile X mental retardation protein deficiency. Further research studies are needed in order to prove a direct association of the cardiovascular problems in fragile X premutation carriers because such knowledge will lead to better preventative treatment.

Keywords: FMR1; arrhythmia; autonomic dysfunction; cardiovascular; fragile X; hypertension; premutation.

PubMed Disclaimer

Figures

FIGURE 1
FIGURE 1
Schematic diagram illustrates mechanisms of cardiovascular problems in the fragile X premutation.
See this image and copyright information in PMC

References

    1. Basuta K., Narcisa V., Chavez A., Kumar M., Gane L., Hagerman R., et al. (2011). Clinical phenotypes of a juvenile sibling pair carrying the fragile X premutation. Am. J. Med. Genet. A. 155A 519–525. 10.1002/ajmg.a.33446 - DOI - PMC - PubMed
    1. Brown D. A., Perry J. B., Allen M. E., Sabbah H. N., Stauffer B. L., Shaikh S. R., et al. (2017). Mitochondrial function as a therapeutic target in heart failure. Nat. Rev. Cardiol. 14 238–250. 10.1038/nrcardio.2016.203 - DOI - PMC - PubMed
    1. Brown S. S. G., Stanfield A. C. (2015). Fragile X premutation carriers: a systematic review of neuroimaging findings. J. Neurol. Sci. 352 19–28. 10.1016/j.jns.2015.03.031 - DOI - PubMed
    1. Buijsen R. A., Sellier C., Severijnen L.-A. W., Oulad-Abdelghani M., Verhagen R. F., Berman R. F., et al. (2014). FMRpolyG-positive inclusions in CNS and non-CNS organs of a fragile X premutation carrier with fragile X-associated tremor/ataxia syndrome. Acta Neuropathol Commun. 2:162. 10.1186/s40478-014-0162-2 - DOI - PMC - PubMed
    1. Buijsen R. A. M., Visser J. A., Kramer P., Severijnen E. A. W. F. M., Gearing M., Charlet-Berguerand N., et al. (2016). Presence of inclusions positive for polyglycine containing protein, FMRpolyG, indicates that repeat-associated non-AUG translation plays a role in fragile X-associated primary ovarian insufficiency. Hum. Reprod. 31 158–168. 10.1093/humrep/dev280 - DOI - PMC - PubMed